SCHEMBL15028634

SCHEMBL15028634

Fc1ccc2nnc(-c3cccc(OCCN4CCOCC4)c3)n2c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.53
KDM4E B2RXH2 3/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
ACHE P22303 1/20 0.47
PIM1 P11309 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 1/20 0.46
EPHX2 P34913 1/20 0.45
SYK P43405 1/20 0.45
KDR P35968 1/20 0.45
MAPK14 Q16539 1/20 0.44
LTA4H P09960 1/20 0.44
SRC P12931 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HTT P42858 1/20 0.43
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284047 0.88 KDM4E (0.47) METKDM4ETP53TSHRADORA2A
SCHEMBL10070557 0.88 KDM4E (0.50) METKDM4ETP53TSHRADORA2A
SCHEMBL1283925 0.88 KDM4E (0.47) METKDM4ETP53TSHRADORA2A
SCHEMBL1284252 0.82 KDM4E (0.43) METKDM4ETP53TSHRADORA2A
SCHEMBL15013794 0.82 KDM4E (0.47) METKDM4ETP53TSHRADORA2A
SCHEMBL1695426 0.82 ACHE (0.44) METKDM4ETP53TSHRADORA2A
SCHEMBL1283918 0.81 ACHE (0.43) METKDM4ETP53TSHRADORA2A
SCHEMBL1284209 0.80 KDR (0.43) METKDM4ETP53TSHRADORA2A
SCHEMBL4200616 0.79 KDR (0.40) METKDM4ETP53TSHRADORA2A
SCHEMBL1284483 0.79 KDR (0.42) METKDM4ETP53TSHRADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788345-B1 DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTALEN-1-YL UREA AND THEIR USE IN THE TREATMENT OF, INTER ALIA, DISEASES OF THE RESPIRATORY TRACT CHIESI FARM SPA (IT) 2020-06-10 EP disclosed
EP-2788345-B1 DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTALEN-1-YL UREA AND THEIR USE IN THE TREATMENT OF, INTER ALIA, DISEASES OF THE RESPIRATORY TRACT CHIESI FARM SPA (IT) 2020-06-10 EP disclosed
US-9458154-B2 Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-10-04 US disclosed
US-9458154-B2 Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-10-04 US disclosed
US-9458154-B2 Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-10-04 US disclosed
US-20150057273-A1 KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-02-26 US disclosed
US-20150057273-A1 KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-02-26 US disclosed
US-20150057273-A1 KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-02-26 US disclosed
WO-2013083206-A1 DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTALEN-1-YL UREA AND THEIR USE IN THE TREATMENT OF, INTER ALIA, DISEASES OF THE RESPIRATORY TRACT CHIESI FARMACEUTICI S.P.A. (IT) 2013-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057273-A1 KINASE INHIBITORS MAPK1, MAP3K1, MAPK4 MET 2444/4885KDM4E 3891/4885TP53 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.